A NEW peptide-based topical
pain reliever is an “ideal
opportunity for Australian
pharmacists to assist their
customers who are looking for new
pain management options,”
according to the product’s maker.
ThermaLIFE Cream targets
arthritic and muscular pain, with
spokesman John Found saying the
company holds international
patents for the peptide technology
utilised in the product, which acts
on key pain pathways.
“With its peptide formulation, we
believe that ThermaLIFE offers
consumers an effective and well
tolerated alternative to other
topical pain relievers,” he said.
Unlike other products it does not
contain heat-generating ingredients
which may irritate the skin, or plant
oils that can stain clothing.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Aug 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Aug 11
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.